A comprehensive view of Biogen Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Biogen Inc. Champions Rare Disease Awareness and Genetic Testing, Fosters Innovation Through Community Collaboration

Biogen achieves perfect score on Disability:IN Equality Index; company introduces 'Essentials' pillars to strengthen culture, collaborates with MS Australia for diagnostic research

US Patent Issued to Biogen MA on July 16 for "Anti-VLA-4 antibodies having reduced effector function" (Massachusetts Inventors)

Anti-Vla-4 Antibodies Having Reduced Effector Function

'LEQEMBI®' (Lecanemab) Approved for the Treatment of Alzheimer’s Disease in Israel

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count